tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr

Clinical trial NCT05360264 · TERMINATED

Trial details

NCT number: NCT05360264
Sponsor: Luca Cardone
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Recurrent

Start date: 2022-01-15
Primary completion: 2024-10-10
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.